Huge, bacteria-eating viruses could be a game-changer for antibiotics that currently struggle to fend off deadly infections.

Strep throat, something we've all had at some point in our lives, is caused by the bacteria Streptococcus pyogenes. Infection ...

Integrating the nanoflowers into a wound dressing helps to fight harmful bacteria while keeping healthy human cells intact.

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

Lung transplant recipients are highly susceptible to infection, the researchers noted, and P. aeruginosa is a leading cause ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

In the face of rising concerns about antibiotic resistant infections, an international group of microbial experts have ...

The need for new fast classification methods has become increasingly important. When a patient arrives at a medical center ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Antibiotics are indispensable for treating bacterial infections. But why are they sometimes ineffective, even when the ...

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...